StockData

LivaNova vs Merit Medical Systems

LIVN and MMSI side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How LIVN and MMSI compare

LivaNova and Merit Medical Systems are about the same size, with market caps of $5.1B and $5.1B.

On earnings, LivaNova is cheaper: it trades at 27.1× trailing earnings, against 31.8× for Merit Medical Systems.

LivaNova grew revenue faster over the last twelve months (12.4% versus 9.1% for Merit Medical Systems).

LivaNova keeps more of each dollar of sales as profit, with a net margin of 12.8% compared with 9.9% at Merit Medical Systems.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricLIVNMMSI
Size and price
Market cap$5.1B$5.1B
Share price$91.92$84.49
Change, 1 year66.0%−0.71%
Change, 5 years10.3%27.8%
Beta (5Y)0.830.33
Employees3,3007,500
StockData Score
Total score1313
Valuation score04 (better)
Growth score4 (better)2
Performance score4 (better)3
Health score5 (better)4
Dividend score00
Valuation
P/E27.1× (better)31.8×
P/S3.4×3.1× (better)
P/B3.8×2.9× (better)
EV/EBITDA25.8×15.5× (better)
P/FCF34.1×24.9× (better)
PEG–1.75
FCF yield2.9%4.0% (better)
Fair value$69.65$92.77
Margin of safety−32.0%8.9% (better)
Growth
Revenue growth (TTM)12.4% (better)9.1%
Revenue growth, 5Y average8.2%9.5% (better)
Net income growth (TTM)–35.2%
EPS growth (TTM)–36.4%
Profitability
Gross margin68.1% (better)49.4%
Operating margin12.7%13.5% (better)
Net margin12.8% (better)9.9%
FCF margin10.1%12.6% (better)
Return on equity15.4% (better)9.8%
Return on invested capital18.2% (better)8.5%
Financial health
Debt / equity0.22 (better)0.42
Net debt / EBITDA−1.190.68 (better)
Interest coverage5.0×6.7× (better)
Current ratio1.454.52 (better)
Altman Z-score2.714.21 (better)
Piotroski F-score57 (better)
Dividends and buybacks
Buyback yield–−0.44%
Shareholder yield0.00% (better)−0.44%
Ownership
Held by institutions108%105%
Held by insiders0.48%2.7%
Insider net buying, 12 months−$1.3M (better)−$2.7M
Short interest, % of float11.6%6.9%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.